Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer’s disease.
Authors:
- James MinersJames Miners
- Carol van HulleCHCarol van Hulle
- Selvi InceSISelvi Ince
- Erin JonaitisEJErin Jonaitis
- Oc OkonkwoOOOc Okonkwo
- Barbara BendlinBBBarbara Bendlin
- Sterling JohnsonSJSterling Johnson
- Cynthia CarlssonCCCynthia Carlsson
- Sanjay AsthanaSASanjay Asthana
- Seth LoveSLSeth Love
- Kaj BlennowKBKaj Blennow
- Henrik ZetterbergHZHenrik Zetterberg
Preprint
- 18 April 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Breakdown of the neurovascular unit in early Alzheimer’s disease (AD) leads to leakiness of the blood-brain barrier (BBB), contributing to cognitive decline and disease pathology. Vascular stability depends on angiopoietin-1 (ANGPT1) signalling, antagonised by angiopoietin-2 (ANGPT2) upon endothelial injury. We have examined the relationship between CSF ANGPT2 and CSF markers of BBB leakiness and disease pathology, across three independent cohorts: (i) 31 AD patients and 33 healthy controls grouped according to their biomarker profile (i.e., AD cases t-tau > 400 pg/mL, p-tau > 60 pg/mL and Aβ42 < 550 pg/mL); (ii) 121 participants in the Wisconsin Registry for Alzheimer’s Prevention or Wisconsin Alzheimer’s Disease Research study (84 participants cognitively unimpaired (CU) enriched for a parental history of AD, 19 participants with mild cognitive impairment (MCI), and 21 with AD); (iii) a neurologically normal cohort aged 23–78 years with paired CSF and serum samples. CSF ANGPT2 level was measured by sandwich ELISA. In cohort (i), CSF ANGPT2 was elevated in AD, correlating with CSF t-tau and p-tau181 but not Aβ42. ANGPT2 also correlated positively with CSF sPDGFRβ and fibrinogen – markers of pericyte injury and BBB leakiness. In cohort (ii), CSF ANGPT2 was highest in MCI. CSF ANGT2 correlated with CSF albumin in the CU and MCI cohorts but not in AD. ANGPT2 also correlated with t-tau and p-tau and with markers of neuronal injury (neurogranin and α-synuclein) and neuroinflammation (GFAP and YKL-40). In cohort (iii), CSF ANGPT2 correlated strongly with the CSF:serum albumin ratio. Increased CSF ANGPT2 and the CSF:serum albumin ratio showed non-significant associations with elevated serum ANGPT2 in this small cohort. Together, these data indicate that CSF ANGPT2 is associated with BBB leakiness in early AD and is closely related to tau pathology and neuronal injury. The utility of serum ANGPT2 as a biomarker of BBB damage in AD requires further study.Keywords
All Related Versions
- Version 1, 2023-04-18, Research Square
- Published version: Translational Psychiatry, 14 (1), 1.
This publication has 37 references indexed in Scilit:
- Angiopoietin-2-induced blood–brain barrier compromise and increased stroke size are rescued by VE-PTP-dependent restoration of Tie2 signalingActa Neuropathologica, 2016
- Increased CSF neurogranin concentration is specific to Alzheimer diseaseNeurology, 2016
- Cerebrovascular disease in ageing and Alzheimer’s diseaseActa Neuropathologica, 2015
- Endothelial LRP1 transports amyloid-β1–42 across the blood-brain barrierJournal of Clinical Investigation, 2015
- Blood-Brain Barrier Breakdown in the Aging Human HippocampusNeuron, 2015
- Cerebrospinal fluid amyloid β40 is decreased in cerebral amyloid angiopathyAnnals of Neurology, 2009
- Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up studyThe Lancet Neurology, 2006
- Increased angiopoietin2 expression is associated with endothelial apoptosis and blood–brain barrier breakdownLaboratory Investigation, 2005
- Angiopoietin-2 and rat brain capillary remodeling during adaptation and deadaptation to prolonged mild hypoxiaJournal of Applied Physiology, 2002
- Hypoxia-Inducible Angiopoietin-2 Expression Is Mimicked by Iodonium Compounds and Occurs in the Rat Brain and Skin in Response to Systemic Hypoxia and Tissue IschemiaThe American Journal of Pathology, 2000